Search Results - "Palace, Jacqueline"
-
1
Trial of Satralizumab in Neuromyelitis Optica Spectrum Disorder
Published in The New England journal of medicine (28-11-2019)“…Relapse of neuromyelitis optica spectrum disorder occurred in 20% of patients who received satralizumab, a subcutaneous anti–interleukin-6 antibody, as…”
Get full text
Journal Article -
2
Time to separate MOG-Ab-associated disease from AQP4-Ab-positive neuromyelitis optica spectrum disorder
Published in Neurology (22-05-2018)Get full text
Journal Article -
3
Effects of immunotherapies and clinical outcomes in neurosarcoidosis: a retrospective cohort study
Published in Journal of neurology (01-07-2021)“…Introduction Neurosarcoidosis is associated with a significant degree of morbidity and mortality and its treatments are varied and complex. There is a paucity…”
Get full text
Journal Article -
4
DOK7 congenital myasthenic syndrome
Published in Annals of the New York Academy of Sciences (01-12-2012)“…Despite being a fairly recent discovery, DOK7 congenital myasthenic syndrome (CMS) is the third most common form of CMS in the United Kingdom. DOK7 is a…”
Get full text
Journal Article -
5
Olfactory threshold as a biomarker of disease activity
Published in Multiple sclerosis (01-05-2023)Get full text
Journal Article -
6
MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines
Published in Lancet neurology (01-03-2016)“…Summary In patients presenting with a clinically isolated syndrome, MRI can support and substitute clinical information in the diagnosis of multiple sclerosis…”
Get full text
Journal Article -
7
Quantitative spinal cord MRI in MOG-antibody disease, neuromyelitis optica and multiple sclerosis
Published in Brain (London, England : 1878) (12-02-2021)“…Spinal cord involvement is a hallmark feature of multiple sclerosis, neuromyelitis optica with AQP4 antibodies and MOG-antibody disease. In this…”
Get full text
Journal Article -
8
Eculizumab in Aquaporin-4–Positive Neuromyelitis Optica Spectrum Disorder
Published in The New England journal of medicine (15-08-2019)“…Neuromyelitis optica spectrum disorder is a relapsing inflammatory disorder of the central nervous system. Two thirds of patients have antibodies against…”
Get full text
Journal Article -
9
Myasthenia gravis
Published in Nature reviews. Disease primers (02-05-2019)“…Myasthenia gravis (MG) is an autoimmune disease caused by antibodies against the acetylcholine receptor (AChR), muscle-specific kinase (MuSK) or other…”
Get full text
Journal Article -
10
Therapeutic strategies for congenital myasthenic syndromes
Published in Annals of the New York Academy of Sciences (01-01-2018)“…To date, more than 25 genes have been implicated in the etiology of the congenital myasthenic syndromes (CMS), and an ever‐growing phenotypic landscape is now…”
Get full text
Journal Article -
11
Clinical presentation and prognosis in MOG-antibody disease: a UK study
Published in Brain (London, England : 1878) (01-12-2017)“…See de Seze (doi:10.1093/brain/awx292) for a scientific commentary on this article. A condition associated with an autoantibody against MOG has been recently…”
Get full text
Journal Article -
12
Double-negative neuromyelitis optica spectrum disorder
Published in Multiple Sclerosis Journal (01-10-2023)“…Most patients with neuromyelitis optica spectrum disorders (NMOSD) test positive for aquaporin-4 antibody (AQP4-IgG) or myelin oligodendrocyte glycoprotein…”
Get full text
Book Review Journal Article -
13
Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis
Published in Brain (London, England : 1878) (01-03-2017)“…Brain imaging characteristics of MOG antibody disease are largely unknown and it is unclear whether they differ from those of multiple sclerosis and AQP4…”
Get full text
Journal Article -
14
Advances and ongoing research in the treatment of autoimmune neuromuscular junction disorders
Published in Lancet neurology (01-02-2022)“…Myasthenia gravis and Lambert-Eaton myasthenic syndrome are antibody-mediated autoimmune diseases of the neuromuscular junction that usually present with…”
Get full text
Journal Article -
15
-
16
Contrasting the brain imaging features of MOG-antibody disease, with AQP4-antibody NMOSD and multiple sclerosis
Published in Multiple sclerosis (01-02-2022)“…Background: Identifying magnetic resonance imaging (MRI) markers in myelin-oligodendrocytes-glycoprotein antibody-associated disease (MOGAD), neuromyelitis…”
Get full text
Journal Article -
17
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: practical considerations
Published in Practical neurology (01-06-2019)“…The field of central nervous system (CNS) inflammatory diseases has recently broadened to include a new condition associated with pathogenic serum antibodies…”
Get more information
Journal Article -
18
Atypical inflammatory demyelinating syndromes of the CNS
Published in Lancet neurology (01-08-2016)“…Summary Atypical inflammatory demyelinating syndromes are rare disorders that differ from multiple sclerosis owing to unusual clinical or MRI findings or poor…”
Get full text
Journal Article -
19
The Neuromuscular Junction and Wide Heterogeneity of Congenital Myasthenic Syndromes
Published in International journal of molecular sciences (05-06-2018)“…Congenital myasthenic syndromes (CMS) are genetic disorders characterised by impaired neuromuscular transmission. This review provides an overview on CMS and…”
Get full text
Journal Article -
20
Management of Juvenile Myasthenia Gravis
Published in Frontiers in neurology (24-07-2020)“…Juvenile Myasthenia Gravis (JMG) is a rare disorder, defined as myasthenia gravis in children younger than 18 years of age. While clinical phenotypes are…”
Get full text
Journal Article